Obesity and type II diabetes mellitus
Hormonal regulation of energy homeostasis
Signal transduction pathways involved in cellular and whole body energetics
Structure function relationship of adipocyte-derived hormones
Research Interests
Energy expenditure is, in part, determined by the metabolic efficiency
with which an organism converts energy into work. Evolution favors high
metabolic efficiency which results in lower energy expenditure and helps
organisms survive starvation. However, with the ready availability of
high calorie food, high metabolic efficiency also predisposes organisms
to obesity. Obesity has reached epidemic proportions globally, particularly
in the US where it afflicts one third of the adult population. Studies
have shown that obesity is tightly linked to insulin resistance and
dyslipidemia and often leads to type II diabetes mellitus and coronary
artery disease. The prevalence of these conditions suggests that coronary
artery disease and type II diabetes are intrinsic responses to excess
fat both in circulation and in metabolically important tissues such
as muscle and adipocytes. The focus of my group is to understand the
molecular, cellular, as well as the whole body physiological basis of
obesity and the metabolic adaptation that develops in response to this
condition.
Students and postdoctoral fellows will have the opportunity to use
state of the art genomic and proteomic tools to identify novel secreted
factors and components of signal transduction pathways. They will employ
modern as well as classic molecular biology, cell biology, and biochemistry
techniques to study protein function and structure. They will also be
expected to learn the methodology used to study cellular and whole body
metabolism.
Areas of research include:
1) Hormonal regulation of obesity and diabetes by adipokine adiponectin
(also known as Acrp30). Adiponectin is an adipocyte-secreted hormone
whose expression and serum concentration are decreased in obese or diabetic
humans and animals. For example, recent studies have show that in Arizona’s
Pima tribe, occurrence of diabetes later in life is accompanied by decreased
adiponectin levels before onset of diabetes. Adiponectin exerts multiple
metabolic actions at a number of tissue sites to enhance insulin sensitivity.
Remarkably, adiponectin exists in a number of distinct forms, each of
which activates different signal transduction pathways. We are currently
investigating the molecular mechanisms by which the oligomerization
state of adiponectin affects its signaling specificity and its ability
to promote insulin action in different tissues.
2) Regulation of AMP-activated protein kinase (AMPK) and cellular energetics
by adipokines/cytokines. AMPK is a serine/threonine protein kinase that
integrates cellular energetics with metabolic pathways and cell growth
or proliferation. Under conditions of cellular energy deficit, manifested
in low ATP/AMP ratio, AMPK becomes activated to shut off biosynthetic
pathways and turn on catabolic pathways. It is the target through which
two different adipokines, leptin and adiponectin, increase fatty acid
oxidation. Currently we are examining the signaling mechanisms used
by leptin and adiponectin to modulate AMPK activity.
Selected publications:
Tsao T.S., E. Tomas, H.E. Murrey, C. Hug, D.H. Lee, N.B. Ruderman,
J.E. Heuser, and H.F. Lodish. Role of disulfide bonds in Acrp30/Adiponectin
structure and signaling specificity: Different oligomers activate
different signal transduction pathways. J Biol Chem
278:50810-50817 (2003).
Tsao, T.S., C. Hug, and H.F. Lodish. Adipokines: Regulators of Metabolic
Integration and Energy Metabolism. Chapter 65 of Diabetes Mellitus:
A Fundamental and Clinical Text, 3rd Edition. D. LeRoith,
S.I. Taylor, and J.M. Olefsky, editors. Lippincott Williams &
Wilkins, publisher (2003)
Tomas E., T.S. Tsao, A.K. Saha, H.E. Murrey, C. Zhang Cc, S.I. Itani,
H.F. Lodish, and N.B. Ruderman. Enhanced muscle fat oxidation and
glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase
inhibition and AMP-activated protein kinase activation. Proc
Natl Acad Sci U S A 99:16309-16313 (2002).
Tsao T.S., H.E. Murrey, C. Hug, D.H. Lee, and H.F. Lodish. Oligomerization
state-dependent activation of NF-kB signaling
pathway by adipocyte complement-related protein of 30 kDa (Acrp30).
J Biol Chem 277:29359-29362 (2002).
Tsao T.S., H.F. Lodish, and J. Fruebis. ACRP30, a new hormone controlling
fat and glucose metabolism. Eur J Pharmacol 440:213-221
(2002).
Tsao T.S., J. Li, K.S. Chang, A.E. Stenbit, D. Galuska, J.E. Anderson,
J.R. Zierath, R.J. McCarter, and M.J. Charron. Metabolic adaptations
in skeletal muscle overexpressing GLUT4: effects on muscle and physical
activity. Faseb J 15:958-969 (2001).
Fruebis J., T.S. Tsao, S. Javorschi, D. Ebbets-Reed, M.R. Erickson,
F.T. Yen, B.E. Bihain, and H.F. Lodish. Proteolytic cleavage product
of 30-kDa adipocyte complement-related protein (Acrp30) increases
fatty acid oxidation in muscle and causes weight loss in mice. Proc
Natl Acad Sci U S A 98:2005-2010 (2001).
Tsao T.S., E.B. Katz, D. Pommer, and M.J. Charron. Amelioration of
insulin resistance but not hyperinsulinemia in obese mice overexpressing
GLUT4 selectively in skeletal muscle. Metabolism 49:340-346
(2000).
Tsao T.S., A.E. Stenbit, S.M. Factor, W. Chen, L. Rossetti, and M.J.
Charron. Prevention of insulin resistance and diabetes in mice heterozygous
for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal
muscle. Diabetes 48:775-782 (1999).
Contact Information
Mailing:
Dr. Tsu-Shuen Tsao, Assistant Professor
Department of Biochemistry & Molecular Biophysics
University of Arizona
1041 E. Lowell Street
Biosciences West 518
Tucson AZ 85721-0088
Telephone: (520) 626-9755
Fax: (520) 626-9204, or -9288
tsushuen@email.arizona.edu